ConductScience.org, home

Paper32320006

Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.

Remie CME and 19 others. Am J Clin Nutr, 2020. Cited by 136 papers, by iCite.

Cite this record

ConductScience Library. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Papers, record 32320006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32320006

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
PubMed
Journal
Am J Clin Nutr
PubMed
Year
2020
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
136
iCite
Relative citation ratio, by iCite
6.75
iCite
Revised in PubMed
2024-07-31
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Remie CMECarlijn M E
2Roumans KHMKay H M
3Moonen MPBMichiel P B
4Connell NJNiels J
5Havekes BBas
6Mevenkamp JJulian
7Lindeboom LLucas
8de Wit VHWVera H W
9van de Weijer TTineke
10Aarts SABMSuzanne A B M
11Lutgens EEsther
12Schomakers BVBauke V
13Elfrink HLHyung L
14Zapata-Pérez RRubén
15Houtkooper RHRiekelt H
16Auwerx JJohan
17Hoeks JJoris
18Schrauwen-Hinderling VBVera B
19Phielix EEsther
20Schrauwen PPatrick

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetylcarnitineMajor topic
Body CompositionMajor topic
Muscle, SkeletalMajor topic
NiacinamideMajor topic
ObesityMajor topic
OverweightMajor topic
Aged
Dietary Supplements
Female
Humans
Male
Middle Aged
NAD
Pyridinium Compounds

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02835664Nicotinamide Riboside and Metabolic HealthDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32412605Fat mobilization without weight loss is a potentially rapid response to nicotinamide riboside in obese people: it's time to test with exercise.https://conductscience.org/library/papers/32412605

Source PubMed

Download CSV of comments and corrections

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11645211Table of nonprotein respiratory quotient: an update.Can J Sport Sci1991https://conductscience.org/library/papers/1645211PubMed
227230286Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice.Sci Rep2016https://conductscience.org/library/papers/27230286PubMed
327552971Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds.Nat Rev Mol Cell Biol2016https://conductscience.org/library/papers/27552971PubMed
428752046Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.Mol Metab2017https://conductscience.org/library/papers/28752046PubMed
527053384Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial.Am J Clin Nutr2016https://conductscience.org/library/papers/27053384PubMed
617452617Ambulatory blood pressure for cardiovascular risk stratification.Circulation2007https://conductscience.org/library/papers/17452617PubMed
731207144Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle.Physiol Rep2019https://conductscience.org/library/papers/31207144PubMed
821102553
Measurement of longitudinal changes in body composition during weight loss and maintenance in overweight and obese subjects using air-displacement plethysmography in comparison with the deuterium dilution technique.
Int J Obes (Lond)2011https://conductscience.org/library/papers/21102553PubMed
922106091Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?Pharmacol Rev2012https://conductscience.org/library/papers/22106091PubMed
1031412242Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.Cell Rep2019https://conductscience.org/library/papers/31412242PubMed
1115137942Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans.Cell2004https://conductscience.org/library/papers/15137942PubMed
1220573749Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance.Diabetes2010https://conductscience.org/library/papers/20573749PubMed
1331491949Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.Int J Mol Sci2019https://conductscience.org/library/papers/31491949PubMed
1427508874Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle.Cell Metab2016https://conductscience.org/library/papers/27508874PubMed
1529992272A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.Am J Clin Nutr2018https://conductscience.org/library/papers/29992272PubMed
1629184669Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study.NPJ Aging Mech Dis2017https://conductscience.org/library/papers/29184669PubMed
1728211258Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet.Mol Nutr Food Res2017https://conductscience.org/library/papers/28211258PubMed
184044103Variability of aerobic performance in the laboratory and its physiologic correlates.Int J Sports Med1985https://conductscience.org/library/papers/4044103PubMed
194351123An enzymatic cycling method for nicotinamide-adenine dinucleotide with malic and alcohol dehydrogenases.Anal Biochem1973https://conductscience.org/library/papers/4351123PubMed
204337382Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clin Chem1972https://conductscience.org/library/papers/4337382PubMed

See all 51 referencesDownload CSV of references

Cited by102

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.

PMIDTitleJournalYearIn PapersSource
42786201Cardiovascular-kidney-metabolic syndrome as a mitochondrial systems disorder.Nat Rev Nephrol2026https://conductscience.org/library/papers/42786201PubMed
42769337Myosteatosis in type 1 diabetes: immunometabolic mechanisms, biomarkers, and therapeutic targets.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42769337PubMed
42708068Precision Nanodelivery Enables Spatiotemporal Control of NAD⁺ Metabolism in Ageing and Disease.Int J Nanomedicine2026https://conductscience.org/library/papers/42708068PubMed
42521674Mitochondrial quality control in health and disease: mechanisms and therapeutic targets.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42521674PubMed
42188047Targeting NAD Homeostasis: Compartmentalization, Quantification, and Modulation.Metabolites2026https://conductscience.org/library/papers/42188047PubMed
42170103Nicotinamide mononucleotide stimulates the activity of bursting slow-oscillation neurons in the supramammillary nucleus and enhances REM sleep.iScience2026https://conductscience.org/library/papers/42170103PubMed
42009009Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.Lancet Neurol2026https://conductscience.org/library/papers/42009009PubMed
41774222Nutrition's role in extending healthspan: CRN-international symposium report.Eur J Nutr2026https://conductscience.org/library/papers/41774222PubMed
41357333Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.EClinicalMedicine2025https://conductscience.org/library/papers/41357333PubMed
41295291Harnessing Metabolomics to Advance Nutrition-Based Therapeutics for Inflammation: A Systematic Review of Randomized Clinical Trials.Metabolites2025https://conductscience.org/library/papers/41295291PubMed
41291376NAD + in fatty liver disease: mechanistic insights and associated targets.Cell Biol Toxicol2025https://conductscience.org/library/papers/41291376PubMed
41083806NAD+ precursor supplementation in human ageing: clinical evidence and challenges.Nat Metab2025https://conductscience.org/library/papers/41083806PubMed
40926126Emerging strategies, applications and challenges of targeting NAD+ in the clinic.Nat Aging2025https://conductscience.org/library/papers/40926126PubMed
40879949Protein Acetylation and NAD+ Homeostasis in Aging Muscle.Adv Exp Med Biol2025https://conductscience.org/library/papers/40879949PubMed
40867810Nicotinamide and Pyridoxine in Muscle Aging: Nutritional Regulation of Redox, Inflammation, and Regeneration.Antioxidants (Basel)2025https://conductscience.org/library/papers/40867810PubMed
40784868Exercise pills for cardiometabolic health cannot mimic the exercise milieu.Trends Endocrinol Metab2026https://conductscience.org/library/papers/40784868PubMed
40775221Nicotinamide phosphoribosyltransferase in NAD+ metabolism: physiological and pathophysiological implications.Cell Death Discov2025https://conductscience.org/library/papers/40775221PubMed
40770531Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial.Geroscience2025https://conductscience.org/library/papers/40770531PubMed
40604314The role of NAD+ metabolism and its modulation of mitochondria in aging and disease.NPJ Metab Health Dis2025https://conductscience.org/library/papers/40604314PubMed
40573093Vitamin B3 Ameliorates Sleep Duration and Quality in Clinical and Pre-Clinical Studies.Nutrients2025https://conductscience.org/library/papers/40573093PubMed

See all 102 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32320006

GET https://conductscience.org/api/papers/v1/32320006/references?page=2